These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 13414335)

  • 21. [The virulence and characteristics of drug resistant tubercle bacilli. I. The virulence of SM resistant, INH resistant KH 1 strain and its purified strains].
    KUDOH S; TOYOHARA M; KIKAWA Y
    Kekkaku; 1957 Oct; 32(10):551-6. PubMed ID: 13492365
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fluctuation in the resistance of various populations of human type tubercle bacillus mixed artificially with sensitive bacilli and resistant variants to isoniazid].
    SATO N
    Kekkaku; 1955 Mar; 30(3):119-22; English summary, 155. PubMed ID: 14382213
    [No Abstract]   [Full Text] [Related]  

  • 23. [The relation between the virulence and enzyme activity of human tubercle bacilli].
    Sato K
    Kekkaku; 1967 Aug; 42(8):307-9. PubMed ID: 4966677
    [No Abstract]   [Full Text] [Related]  

  • 24. [Heterogeneity of catalase levels in populations of isoniazid-resistant Mycobacterium tuberculosis].
    KREIS B; LE JOUBIOUX E; PARIENTE D
    Ann Inst Pasteur (Paris); 1956 Dec; 91(6):932-5. PubMed ID: 13395033
    [No Abstract]   [Full Text] [Related]  

  • 25. Relation between catalase activity, virulence and drug resistance of some strains of Mycobacterium tuberculosis isolated from pathological human specimens.
    FISSI-MARRACCINI G; GUERRA M
    Boll Ist Sieroter Milan; 1959; 38(3-4):106-13. PubMed ID: 13651411
    [No Abstract]   [Full Text] [Related]  

  • 26. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
    Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
    J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands.
    van Doorn HR; de Haas PE; Kremer K; Vandenbroucke-Grauls CM; Borgdorff MW; van Soolingen D
    Clin Microbiol Infect; 2006 Aug; 12(8):769-75. PubMed ID: 16842572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro.
    COHN ML; MIDDLEBROOK G; RUSSELL WF
    J Clin Invest; 1959 Aug; 38(8):1349-55. PubMed ID: 13673091
    [No Abstract]   [Full Text] [Related]  

  • 29. [Significance of drug-resistant tubercle bacilli in the appearance of complications after pulmonary resection].
    DANBARA H; OGAWA Y; HASHIMOTO H; YOSHITATSU S; TSUBOI K; MATSUNAGA K; ABO S; SAEKI B
    Iryo; 1962 Sep; 16():430-7. PubMed ID: 14024855
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on the virulence of isoniazid-resistant strains of human tubercule bacilli by the homogenization of the whole body of infected mice].
    MIKI K; KATO M; MATSUNAGA K
    Kekkaku; 1958 Aug; 33(8):568-70; English abstract, 581. PubMed ID: 13588767
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on the virulence of isonicotinic acid hydrazide-resistant tubercle bacilli. I. The relation between the virulence & the grade of INH resistance].
    SUGIMOTO H
    Kekkaku; 1958 Sep; 33(9):608-12; English abstract 646. PubMed ID: 13599182
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple mutations in katG and inhA identified in Thai isoniazid-resistant Mycobacterium tuberculosis isolates.
    Khadka DK; Eampokalap B; Panitchakorn J; Ramasoota P; Khusmith S
    Southeast Asian J Trop Med Public Health; 2007 Mar; 38(2):376-82. PubMed ID: 17539290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the virulence of bacilli highly resistant to INH. Observations for 1 year after airborne infection].
    SHIMOIDE H; TOYOHARA M
    Kekkaku; 1963 Jan; 38():23-9. PubMed ID: 13988548
    [No Abstract]   [Full Text] [Related]  

  • 34. [Virulence of tuberculosis bacilli resistant to isoniazid].
    NOUFFLARD H
    Ann Inst Pasteur (Paris); 1955 Mar; 88(3):325-35. PubMed ID: 13403292
    [No Abstract]   [Full Text] [Related]  

  • 35. [Relation of catalase activity, isoniazid-resistance and pathogenicity of isoniazid-resistance strains].
    KREIS B; LE JOUBIOUX E
    Ann Inst Pasteur (Paris); 1957 Feb; 92(2):190-6. PubMed ID: 13411679
    [No Abstract]   [Full Text] [Related]  

  • 36. [Stability in the virulence of two human type tubercle bacilli strains H2 and H37 Rv].
    HASHIMOTO T; YOSHIDA K
    Kekkaku; 1954 Jun; 29(6):221-4; English abstract, 235. PubMed ID: 13175318
    [No Abstract]   [Full Text] [Related]  

  • 37. [Catalase activity and virulence of the human type M. tuberculosis].
    ROSA A
    Riv Patol Clin; 1962; 17():123-8. PubMed ID: 13974733
    [No Abstract]   [Full Text] [Related]  

  • 38. Multiple drug resistance and virulence of mycobacterium tuberculosis; a preliminary communication.
    NASSAU E; HAMILTON GM
    Tubercle; 1955 Sep; 36(9):281-2. PubMed ID: 13274545
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experimental studies on the effects of chemotherapy on virulence of tubercle bacteria].
    VELTMAN G
    Tuberkulosearzt; 1957 Jan; 11(1):14-9. PubMed ID: 13409601
    [No Abstract]   [Full Text] [Related]  

  • 40. [Virulence and catalase activity of isoniazid-resistant human tubercle bacilli].
    TAKAHASHI Y; KUZE A; ARIMA J; YAMAMOTO K
    C R Seances Soc Biol Fil; 1956; 150(10):1837-40. PubMed ID: 13414335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.